News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘ColonCancer’ clear

  • The reduced risk of colorectal cancer associated with taking aspirin or NSAIDs may be confined to individuals already at risk because of elevations in a particular inflammatory factor in the blood, researchers at Dana-Farber Cancer Institute and Massachusetts General Hospital report.

Tags: ColonCancer, Prevention

  •  

    Patients with colon cancer who used multivitamins did not reduce the risk of cancer recurrence, though there may be some benefit to patients 60 and younger.

Tags: ColonCancer

  • Researchers found patients who engaged in moderate physical activity were 53 percent more likely to be free of colorectal cancer than those who were less physically active.

Tags: ColonCancer

  • An observational study is among the first to show that aspirin can improve survival in colorectal cancer patients who started taking aspirin following diagnosis.

Tags: ColonCancer

  • The vast majority of advanced colon cancer patients in a clinical trial were not concerned about the cost of prescription drugs, according to a study led by Dana-Farber researchers.

Tags: chemotherapy, ColonCancer

  • A combination of chemotherapies for colon cancer decreases recurrence for patients under 70, but not for those who are older, according to Mayo Clinic and Dana-Farber scientists.

Tags: chemotherapy, BasicResearch, ColonCancer

  • Research explores why people with surgically removed colorectal cancer who are overweight, physically inactive, and follow a Western-pattern diet may have increased risk of dying from the disease or other causes.

Tags: ColonCancer

  • Dana-Farber scientists show a previously unsuspected gene can also influence transcription factors and potentially disable tumor cells.

Tags: ColonCancer, Genetics

  • Patients diagnosed with colon cancer who had abundant vitamin D in their blood were less likely to die during a follow-up period than those who were deficient in the vitamin, according to a new study by scientists at Dana-Farber Cancer Institute.

Tags: ColonCancer

  • Researchers at Dana-Farber have uncovered a cancer paradox: A family history of colon or rectal cancer doubles one's risk of the disease — but improves the odds of survival should the cancer develop.

Tags: ColonCancer

Showing 11-20 of 23 items